CBD Seed Europe in the Media
September 21, 2022

We are getting more and more exposure in the media. Find the latest article in Business Cann about us here.

https://businesscann.com/newly-approved-european-hemp-seeds-to-deliver-record-levels-of-cbd/

If you want more info, please contact us today.

Other News

CBD Seed Update October 2022

CBD Seed Update October 2022

With the registration of our CBD Northwest and Midwest genetics in the European Common Catalogue, we have been getting a lot of attention from the industry and the media. See the latest article in Hemp Today:

read more
CBD Seed Europe Keynote EIHA 2022

CBD Seed Europe Keynote EIHA 2022

CBD Seed Europe were lucky enough to be invited to speak on the breeding and genetics panel where Francesco Folcarelli gave a speech and took part in the discussion. 

read more
Canapa Mundi Rome 2022

Canapa Mundi Rome 2022

Our most important takeaway from Canapa Mundi was that everyone seems to be on the same page as us that the way forward for the hemp sector is to move away from the gray legal framework that the industry has been based on to go towards a much clearer and well defined industry where everyone from farmer to Government agency is in complete understanding of what is and is not legal as it relates to CBD.

read more
Highest CBD EU certified seed. Now Available!

Highest CBD EU certified seed. Now Available!

Our years of hard work and dedication has been celebrated by the European department of agriculture. Two of our high CBD, low THC strains have been registered into the EU seed catalog and received their Blue Label.

read more
Is CBD the answer to the Covid-19 Pandemic?

Is CBD the answer to the Covid-19 Pandemic?

Richard Van Breemen Ph.D and his team of researchers recently published their findings in The Journal of Natural Products. The study found that a number of Hemp derived compounds such as CBGA and CBDA can bind themselves to the SARS-CoV-2 spike protein, which blocks a critical step in the infection process in humans. This is the same process pharmaceutical companies use in the development of Covid-19 vaccines.

read more